British Columbia Securities Commission - Cease Trade Order
Dec 13, 2010
OTC Disclosure & News Service
Vancouver, BC, Canada -
2010 BCSECCOM 674
Cease Trade Order
Biotech Holdings Ltd.
Section 164 of the Securities Act, R.S.B.C. 1996, c. 418
¶ 1 Biotech Holdings Ltd. is an OTC reporting issuer under BC Instrument 51-509 Issuers Quoted in the U.S. Over-the-Counter Markets(BCI 51-509).
¶ 2 Biotech Holdings has not filed:
1. comparative annual financial statements for its financial years ended March 31, 2009 and March 31, 2010, as required under Part 4 of National Instrument 51-102 Continuous Disclosure Obligations(NI 51-102) and section 5(b) of BCI 51-509,
2. interim financial statements for the interim periods ended June 30, 2009, September 30, 2009, December 30, 2009, June 30, 2010 and September 30, 2010 as required under Part 4 of NI 51-102 and section 5(b) of BCI 51-509,
3. a Form 51-102F1 Management's Discussion and Analysisfor the periods ended March 31, 2009, June 30, 2009, September 30, 2009, December 31, 2009, March 31, 2010, June 30, 2010 and September 30, 2010 as required under Part 5 of NI 51-102 and section 5(b) of BCI 51-509, and
4. a Form 51-102F2 Annual Information Formfor the years ended March 31, 2009 and March 31, 2010 as required under section 5(c) of BCI 51-509
(the required records).
¶ 3 Under section 164(1) of the Act, the Executive Director orders that all trading in the securities of Biotech Holdings cease until:
1. it files the required records, completed in accordance with the Act and rules, and
2. the Executive Director makes an order under section 164 of the Act revoking this order.
¶ 4 December 13, 2010
Allan Lim, CA
Manager
Corporate Finance
Billionaire Philanthropist: "Bobby (Sager) 'You can teach a man to fish, but if you teach a man to fish all he's going to eat is fish. If you teach him how to package the fish, and market the fish and ship the fish, he can also get some potatoes and some
